62.5 C+
Selank
Also known as: TP-7
Strong Clinical Evidence Research Chemical
Research Evidence 60.0/100
Safety Profile 65.0/100
11 Clinical Trials
Unknown: 1 PHASE3: 2 NA: 8
- The Study on Effects of Acute Exposure to High Altitude Hypoxia on Cognitive Function in Lowlanders Unknown Phase COMPLETED Xijing Hospital
- Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy PHASE3 COMPLETED UCB Pharma SA
- Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures PHASE3 COMPLETED UCB Pharma
- The Effect of Balance Exercises on Cognitive Function NA COMPLETED Istanbul Medipol University Hospital
- Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia NA UNKNOWN Bambino Gesù Hospital and Research Institute
Showing 5 of 11 trials.
19 Research Papers
- Efficiency evaluation of wastewater treatment by three macrophytes using a pilot-constructed wetland system in Ota, Nigeria. J Water Health unknown
- [Pathophysiological aspects of primary Sjögren's disease : From epithelial activation to systemic autoimmunity]. Z Rheumatol Review
- Improving the nutritional value and bioactivity of soybean meal in solid-state fermentation using Bacillus strains newly isolated from the gut of the termite Termes propinquus. FEMS Microbiol Lett unknown
- Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Bull Exp Biol Med unknown
- RISK OF HOSPITAL MORTALITY IN CRITICALLY ILL PATIENTS WITH TRANSIENT AND PERSISTENT THROMBOCYTOPENIA: A RETROSPECTIVE STUDY. Shock unknown
Showing 5 of 19 papers by citation count.
FDA Data
Not FDA-Approved
Selank has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
Frequently Asked Questions
Is Selank FDA approved?
No, Selank has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has Selank been studied in?
Selank has been studied in 11 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for Selank?
Selank has a CheckPeptides trust score of 62.5/100 (grade: C+). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026
Quick Facts
- Classification
- Anxiolytic nootropic peptide
- Molecular Weight
- 751.9 Da
- PubChem
- CID 11765600 ↗
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 60.0/100
Safety Profile 65.0/100
Evidence Summary
- Clinical Trials
- 11
- Research Papers
- 19
- Trust Score
- 62.5/100
- Grade
- C+